Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases

MH Park, MR Jo, YR Kim, CK Lee, JT Hong - Pharmacology & Therapeutics, 2016 - Elsevier
Peroxiredoxins (PRDXs) are antioxidant enzymes, known to catalyze peroxide reduction to
balance cellular hydrogen peroxide (H 2 O 2) levels, which are essential for cell signaling …

MicroRNA expression and association with clinicopathologic features in papillary thyroid cancer: a systematic review

P Aragon Han, CH Weng, HT Khawaja, N Nagarajan… - Thyroid, 2015 - liebertpub.com
Background: Studies have suggested that microRNAs (miR) may be useful prognostic
markers and are associated with aggressive clinicopathologic features in papillary thyroid …

Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears

G Lithwick-Yanai, N Dromi, A Shtabsky… - Journal of clinical …, 2017 - jcp.bmj.com
Aims The distinction between benign and malignant thyroid nodules has important
therapeutic implications. Our objective was to develop an assay that could classify …

Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules

V Marotta, G Russo, C Gambardella, M Grasso… - Chemosphere, 2019 - Elsevier
Pollutants represent potential threats to the human health, being ubiquitous in the
environment and exerting toxicity even at low doses. This study aims at investigating the role …

The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma

R Vita, A Ieni, G Tuccari, S Benvenga - Reviews in Endocrine and …, 2018 - Springer
Although the incidence of some malignancy has decreased over the recent years, this is not
the case of papillary thyroid microcarcinoma (PTMC), whose incidence has increased …

Association of BRAFV600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four …

P Aragon Han, H Kim, S Cho, R Fazeli, A Najafian… - Thyroid, 2016 - liebertpub.com
Background: Studies have demonstrated an association of the BRAFV600E mutation and
microRNA (miR) expression with aggressive clinicopathologic features in papillary thyroid …

Single point mutations in pediatric differentiated thyroid cancer

AS Alzahrani, AK Murugan, E Qasem, M Alswailem… - Thyroid, 2017 - liebertpub.com
Purpose: Differentiated thyroid cancer (DTC) is rare in children. Previous studies have
suggested that it has different clinicopathologic features and mutation profiles compared …

The role of miRNA in papillary thyroid cancer in the context of miRNA Let-7 family

E Perdas, R Stawski, D Nowak… - International journal of …, 2016 - mdpi.com
Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy. RET/PTC
rearrangement is the most common genetic modification identified in this category of cancer …

Aggressive differentiated thyroid cancer

N Janjua, VB Wreesmann - European Journal of Surgical Oncology, 2018 - Elsevier
Differentiated thyroid cancer is characteristically associated with an innocuous clinical
course, but a minority of cases may manifest surprisingly aggressive behaviour. Such …

[HTML][HTML] Differential expression of MicroRNAs in papillary thyroid carcinoma and their role in racial disparity

R Suresh, S Sethi, S Ali, T Giorgadze… - Journal of cancer …, 2015 - ncbi.nlm.nih.gov
Objective MicroRNAs (miRNAs) are known to play important roles in the diagnosis and
prognosis of papillary thyroid cancer (PTC), and they are useful in developing targeted …